A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab |
| |
| Authors: | Miguel Nogueira MD Joel Reis MD Maria Abreu MD André Coelho MD Cláudia F. Reis MD Susana Machado MD |
| |
| Affiliation: | 1. Dermatology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal;2. Medical Genetics Center Dr. Jacinto Magalhães, Centro Hospitalar Universitário de Santo António, Porto, Portugal;3. Pathology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal |
| |
| Abstract: | CARD14-associated papulosquamous eruption (CAPE) is a rare inflammatory skin eruption that can have features of psoriasis, pityriasis rubra pilaris, and erythroderma. This skin condition is known for its resistance to topical or conventional systemic therapies. Successful treatment of CAPE with anti-IL-12/IL-23 and IL-17 inhibitors has been reported. We present a case of a 2-year-old girl with CAPE who was successfully treated with ustekinumab. |
| |
| Keywords: | erythroderma pediatric ustekinumab |
|
|
